Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ratko Djukanovic

Showing results (61-70 of 127) with videos related to

Pageof 13
Sort By:
ERJ Open Research|November 19, 2025
Economic impact of steroid-induced comorbidities in severe asthma: a SHARP CRC simulationBarbara Mascialino, Aruna T Bansal, Elisabeth Bel, et al.
The Lancet. Respiratory Medicine|December 18, 2017
Physiotherapy breathing retraining for asthma: a randomised controlled trialAnne Bruton, Amanda Lee, Lucy Yardley, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 15, 2026
Perception phenotypes in difficult-to-treat asthma based on asthma control reported by patients and lung functionLiuyu Wei, Sabina Stanescu, Matthew Harvey, et al.
The Journal of Allergy and Clinical Immunology|March 20, 2020
Connectivity patterns between multiple allergen specific IgE antibodies and their association with severe asthmaGraham Roberts, Sara Fontanella, Anna Selby, et al.
The European Respiratory Journal|December 22, 2022
Identifying and appraising outcome measures for severe asthma: a systematic reviewAnna Rattu, Ekaterina Khaleva, Chris Brightling, et al.
The European Respiratory Journal|August 31, 2019
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questionsArnaud Bourdin, Leif Bjermer, Christopher Brightling, et al.
The Journal of Allergy and Clinical Immunology|May 1, 2020
Sputum microbiome profiles identify severe asthma phenotypes of relative stability at 12 to 18 monthsMahmoud I Abdel-Aziz, Paul Brinkman, Susanne J H Vijverberg, et al.
BMC Pulmonary Medicine|May 26, 2019
Protocol for the Wessex AsThma CoHort of difficult asthma (WATCH): a pragmatic real-life longitudinal study of difficult asthma in the clinicAdnan Azim, Heena Mistry, Anna Freeman, et al.
ERJ Open Research|August 28, 2025
Urinary thromboxane and isoprostane levels are elevated in symptom-high T2-biomarker-low severe asthmaMatthew Chad Eastwood, John Busby, Johan Kolmert, et al.
The Journal of Allergy and Clinical Immunology|July 4, 2006
Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterolNizar N Jarjour, Susan J Wilson, Steven M Koenig, et al.
Pageof 13

Showing results (61-70 of 127) with videos related to

Sort By:
Pageof 13
ERJ Open Research|November 19, 2025
Economic impact of steroid-induced comorbidities in severe asthma: a SHARP CRC simulationBarbara Mascialino, Aruna T Bansal, Elisabeth Bel, et al.
The Lancet. Respiratory Medicine|December 18, 2017
Physiotherapy breathing retraining for asthma: a randomised controlled trialAnne Bruton, Amanda Lee, Lucy Yardley, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 15, 2026
Perception phenotypes in difficult-to-treat asthma based on asthma control reported by patients and lung functionLiuyu Wei, Sabina Stanescu, Matthew Harvey, et al.
The Journal of Allergy and Clinical Immunology|March 20, 2020
Connectivity patterns between multiple allergen specific IgE antibodies and their association with severe asthmaGraham Roberts, Sara Fontanella, Anna Selby, et al.
The European Respiratory Journal|December 22, 2022
Identifying and appraising outcome measures for severe asthma: a systematic reviewAnna Rattu, Ekaterina Khaleva, Chris Brightling, et al.
The European Respiratory Journal|August 31, 2019
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questionsArnaud Bourdin, Leif Bjermer, Christopher Brightling, et al.
The Journal of Allergy and Clinical Immunology|May 1, 2020
Sputum microbiome profiles identify severe asthma phenotypes of relative stability at 12 to 18 monthsMahmoud I Abdel-Aziz, Paul Brinkman, Susanne J H Vijverberg, et al.
BMC Pulmonary Medicine|May 26, 2019
Protocol for the Wessex AsThma CoHort of difficult asthma (WATCH): a pragmatic real-life longitudinal study of difficult asthma in the clinicAdnan Azim, Heena Mistry, Anna Freeman, et al.
ERJ Open Research|August 28, 2025
Urinary thromboxane and isoprostane levels are elevated in symptom-high T2-biomarker-low severe asthmaMatthew Chad Eastwood, John Busby, Johan Kolmert, et al.
The Journal of Allergy and Clinical Immunology|July 4, 2006
Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterolNizar N Jarjour, Susan J Wilson, Steven M Koenig, et al.
Pageof 13